ArticleBreast cancer research : BCR2015

Anti-HER2 CD4(+) T-helper type 1 response is a novel immune correlate to pathologic response following neoadjuvant therapy in HER2-positive breast cancer.

Jashodeep Datta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.